Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Brexpiprazole in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update showing results posting for brexpiprazole in adults with schizophrenia. The study (NCT01810783) has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • brexpiprazole (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2017-02-23